top of page

Corporate Advisory Council

The American Brain Coalition (ABC) is a unique nonprofit membership organization drawn from patients, researchers, clinicians, universities, government agencies, and corporations. Together, we raise awareness for increased support of research that leads to better treatment; services and support that improves patients’ quality of life; as well as a national commitment towards finding cures for individuals with disabling neurological and psychiatric disorders.

​

Corporate members within the ABC are comprised of leading companies that recognize the importance of partnering with those committed to helping people with brain diseases and disorders. Corporate members include pharmaceutical, biotech, and medical device companies that are developing or marketing therapeutic or diagnostic products.

​

ABC corporate members may designate one individual to represent them on the ABC’s Corporate Advisory Council (CAC). The Council provides unique opportunities for companies to engage with experts in the brain disease community, not only with patient advocacy organizations, but also with top scientific, clinical, and policy experts and leaders in the worldwide central nervous system space.

CORPORATE ADVISORY COUNCIL MEMBERS

Caterina Azais

Aequa Nanotherapeutics

image_2026-10-28_134212869.png

Deena Andreola

Takeda Pharmaceuticals America Inc.

image_2026-10-28_134349425.png

Ranya Belmaachi

Subsense, Inc.

image_2026-10-28_134605207.png

Todd Bledsoe

Neurocrine Biosciences, Inc.

image_2026-10-28_135018055.png

Klaus Dahmen

QuantalX Neuroscience

image_2026-10-28_135052866.png

Matthew Devino

Bristol Myers Squibb

image_2026-10-28_135202906.png

Caroline Fisher-O'Neill

Otsuka America Pharmaceutical

image_2026-10-28_135327743.png

Julie Garner

Definium Therapeutics

image_2026-10-28_135358967.png

Shannon Gilbert

Teva Pharmaceuticals

image_2026-10-28_135506815.png

Rob Goldstein-Mahon

Ionis Pharmaceuticals, Inc.

image_2026-10-28_135848478.png

Mike Hanley

Alto Neuroscience

image_2026-10-28_135923611.png

Marybeth Howlett

Eli Lilly & Company

image_2026-10-28_140025193.png

Ashley John

Novartis Pharmaceuticals Corporation

image_2026-10-28_140200130.png

Kate Madigan

Eisai, Inc.

image_2026-10-28_140225481.png

Daniel Masson

Flow Neuroscience

image_2026-10-28_140253333.png

Retsina Meyer, PhD

Delix Therapeutics

image_2026-10-28_140326232.png

Landan Mintch

Motif Neurotech

Eric Rasmussen.png

Eric Rasmussen

Compass Pathways
 

image_2026-10-28_140418638.png

Parisa Sanandaji

Stoke Therapeutics

image_2026-10-28_140445390.png

Brian Spar

Praxis Precision Medicines

image_2026-10-28_140617250.png

Sarah Tellock

Acadia Pharmaceuticals

image_2026-10-28_134856983.png

TBD

Precision Neuroscience

image_2026-10-28_140700304.png

Tim Vaske

Genentech

bottom of page